CN Patent

CN108883106A — 使用了乐伐替尼和依维莫司的肾细胞癌治疗

Assigned to Sanitary Material R&d Management Co ltd · Expires 2018-11-23 · 7y expired

What this patent protects

提供了用乐伐替尼或其药学上可接受的盐和依维莫司的组合对肾细胞癌进行治疗的方法和组合物。还提供了在出现不良事件时特别有用的剂量和剂量调整。

USPTO Abstract

提供了用乐伐替尼或其药学上可接受的盐和依维莫司的组合对肾细胞癌进行治疗的方法和组合物。还提供了在出现不良事件时特别有用的剂量和剂量调整。

Drugs covered by this patent

Patent Metadata

Patent number
CN108883106A
Jurisdiction
CN
Classification
—
Expires
2018-11-23
Drug substance claim
No
Drug product claim
No
Assignee
Sanitary Material R&d Management Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.